BackGreenway Greenhouse Cannabis Overview

Greenway Greenhouse Cannabis EBIT

Track Greenway Greenhouse Cannabis's EBIT ($-1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$369.13K
↓ 389.69% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$1.80M
↓ 221.48% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Greenway Greenhouse Cannabis (GWAY.CN) FAQ

The latest EBIT for GWAY.CN is $-1.8M as of June 2026. That compares with $-560K in the prior-year period — down 221.5% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside Greenway Greenhouse Cannabis's historical trend and sector peers before judging valuation or financial health.

Over the past year, GWAY.CN's EBIT moved from $-560K to $-1.8M — a 221.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Greenway Greenhouse Cannabis's operating scale or balance-sheet position.

Against its sector companies, GWAY.CN currently prints $-1.8M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Greenway Greenhouse Cannabis's growth, margins, and balance sheet.

A EBIT figure of $-1.8M for GWAY.CN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting GWAY.CN's EBIT ($-1.8M), review year-over-year change from $-560K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.